5LMD
The crystal structure of hCA II in complex with a benzoxaborole inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-06-27 |
Detector | RIGAKU SATURN 944 |
Wavelength(s) | 1.54178 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 42.427, 41.493, 72.149 |
Unit cell angles | 90.00, 104.40, 90.00 |
Refinement procedure
Resolution | 50.000 - 1.700 |
Rwork | 0.166 |
R-free | 0.20090 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 1ca2 |
RMSD bond length | 0.013 |
RMSD bond angle | 1.649 |
Data reduction software | d*TREK |
Data scaling software | SCALEPACK |
Phasing software | CNS |
Refinement software | CNS |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 1.730 |
High resolution limit [Å] | 1.700 | 4.610 | 1.700 |
Rmerge | 0.081 | 0.036 | 0.333 |
Number of reflections | 25797 | ||
<I/σ(I)> | 9.7 | ||
Completeness [%] | 95.4 | 99 | 70.9 |
Redundancy | 7.2 | 8.2 | 3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8.7 | 293 | 1.4 M Sodium Citrate 0.1 M Tris-HCl |